Modified bi-weekly cetuximab-cisplatin and 5-FU/leucovorin based regimen for effective treatment of recurrent/metastatic head and neck squamous cell carcinoma to reduce chemotherapy exposure of patients

  • Amichay Meirovitz
  • , Shani Bergerson
  • , Nir Hirshoren
  • , Jeffrey M. Weinberger
  • , Evgeniya Bersudski
  • , Sharon Daniel
  • , Kim Sheva
  • , Cesar A. Perez

    Research output: Contribution to journalArticlepeer-review

    3 Scopus citations

    Fingerprint

    Dive into the research topics of 'Modified bi-weekly cetuximab-cisplatin and 5-FU/leucovorin based regimen for effective treatment of recurrent/metastatic head and neck squamous cell carcinoma to reduce chemotherapy exposure of patients'. Together they form a unique fingerprint.

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science